@article{73dc65fe8c7a44909a79c1897c0793f1,
title = "Long-Acting Cabotegravir/Rilpivirine Concentrations in Combination With Intravenous Rifampin: A Case Report",
abstract = "As antiretroviral therapy advancements focus on long-acting medications, there is a need to assess the potential impact of drug–drug interactions. We present a real-world case of long-acting cabotegravir/rilpivirine co-administered with intravenous rifampin.",
keywords = "drug-drug interactions, long-acting cabotegravir/ rilpivirine, plasma concentrations, rifamycins",
author = "Sunagawa, {Shawnalyn W.} and Havens, {Joshua P.} and Anthony Podany and Bryan Walker and Scarsi, {Kimberly K.} and Bares, {Sara H.}",
note = "Publisher Copyright: {\textcopyright} The Author(s) 2023. Published by Oxford University Press on behalf of Infectious Diseases Society of America. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.",
year = "2023",
month = dec,
day = "1",
doi = "10.1093/ofid/ofad604",
language = "English (US)",
volume = "10",
journal = "Open Forum Infectious Diseases",
issn = "2328-8957",
publisher = "Oxford University Press",
number = "12",
}